论文部分内容阅读
目的:观察盐酸氨溴索注射液雾化吸入治疗小儿肺炎的临床疗效。方法:选取于2013年1月-2014年2月来院治疗的小儿肺炎患者110例作为研究对象,随机数字表法分为对照组和观察组,各组55例,均给予常规治疗,对照组采取糜蛋白酶疗法,观察组采用盐酸氨溴索注射液雾化吸入治疗,比较两组患者的临床效果。结果:观察组的总有效率为98.18%,显著高于对照组的87.27%,差异具有统计学意义(P<0.05);观察组的咳嗽消失时间、退热时间、肺部啰音消失时间、住院时间,均优于对照组,差异具有统计学意义(P<0.05);观察组不良反应发生率(7.27%)明显低于对照组的(20.00%),差异具有统计学意义(P<0.05)。结论:小儿肺炎采取盐酸氨溴索注射液雾化吸入治疗的临床效果显著,不良反应少,安全性好。
Objective: To observe the clinical effect of inhalation of ambroxol hydrochloride in children with pneumonia. Methods: A total of 110 children with pneumonia admitted to our hospital from January 2013 to February 2014 were selected as the research object. The random number table was divided into control group and observation group. 55 cases in each group were given routine treatment and the control group Chymotrypsin therapy, observation group ambroxol hydrochloride injection inhalation therapy, the clinical effect of two groups were compared. Results: The total effective rate in the observation group was 98.18%, which was significantly higher than that in the control group (87.27%), the difference was statistically significant (P <0.05); the cough disappearance time, the antipyretic time, the pulmonary rales disappearance time, (P <0.05). The incidence of adverse reactions in the observation group (7.27%) was significantly lower than that in the control group (20.00%), the difference was statistically significant (P <0.05 ). Conclusion: The clinical effect of inhalation of ambroxol hydrochloride in children with pneumonia is obvious, with few adverse reactions and good safety.